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CHAPTER I 
 
INTRODUCTION 
 
Bone Defect Repair 
 Every year, roughly two million patients worldwide undergo a bone grafting procedure to repair a 
bone defect caused by trauma, congenital defects, tumor excision, or disease1. The gold standard 
treatment is to harvest the bone graft from an autologous source on the patient’s iliac crest, though the 
required second surgery and harvest-site morbidity concerns2 make this treatment method problematic. 
The use of allograft bone has also been explored for treating bone defects, though potential negative 
patient immunologic responses from these materials can limit their effectiveness. Therefore, much 
effort has been devoted to developing tunable synthetic materials that promote bone regrowth but are 
safely tolerated by the patient’s body. Implantable devices made with poly(methyl methacrylate) 
(PMMA) have been clinically used for bone replacement/fixation owing to their robust mechanical 
properties which can closely mimic those of native bone tissue3. However, PMMA cannot be resorbed 
by the body and can induce an inflammatory response4. Injectable calcium phosphate (CaP) bone 
cements have shown promise as a synthetic bone graft substitute, though treatment effectiveness has 
been limited by mismatches between rate of CaP degradation and the rate of new tissue growth5.  
Thus, there exists a substantial need for biomaterials that foster new bone tissue growth, exhibit 
biocompatibility in both the bulk material and the degradation byproducts, provide mechanical stability 
at the wound site, and effectively match the rate of new tissue growth with the rate of material 
biodegradation. 
 
Poly(ester-urethane) Tissue Engineering Scaffolds 
Biodegradable scaffolds made from synthetic polymers have been extensively investigated for 
use in tissue engineering and regenerative medicine, including bone defect repair applications.  
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Examples include poly(lactic-co-glycolic acid) (PLGA) 6, 7, poly(ε-caprolactone) (PCL) 8, 9, 
polyanhydrides (PAA) 10, 11, and polyurethanes 12, 13, all of which have a history of use in products 
approved by the FDA 14-17. These materials are applicable for a diverse range of regenerative 
applications because they offer a high degree of tunability, generate a minimal host inflammatory 
response, and degrade into non-cytotoxic components 18, 19 that are resorbed and cleared from the 
body 20, 21.  
In situ curing, injectable scaffolds such as poly(ester urethanes) (PEURs) that support cellular 
infiltration and degrade into non-toxic breakdown products represent a particularly promising class of 
biomaterial 22. Porous PEUR scaffolds are formed by mixing hydroxyl-functionalized polyols (e.g., 900 g 
mol-1 triols comprised of caprolactone, glycolide, and D,L-lactide) 18 with isocyanate-functional 
precursors to form a  crosslinked network. Water can be added as a blowing agent to create an inter-
connected pore structure, and the mechanical, chemical, and degradation properties of the scaffold can 
be modified through the selection of the polyol and isocyanate precursors 23, 24. Unlike many other 
techniques used for fabrication of porous scaffolds, this approach does not require a porogen leaching 
step.  This in situ foaming method, combined with the relatively short working time of the reactive liquid 
mixture 25, renders PEURs useful as injectable and settable scaffolds suitable for minimally invasive 
procedures in the clinic for the repair of bone defects. 
PEUR scaffolds are primarily degraded by acid-catalyzed hydrolysis of ester bonds in the 
amorphous soft segment, resulting in chain scission and formation of hydroxyl and carboxylic acid end 
groups. Residual carboxylic acids in the polymer reduce the local pH at later stages of degradation 26, 
27, thereby catalyzing accelerated hydrolysis of the polymer 28.  As the polymers degrade, low molecular 
weight and soluble α-hydroxy acids diffuse from the scaffold into the medium, resulting in mass loss. 
Although α-hydroxy acids are non-toxic and can be cleared from the body 18, 29, autocatalytic 
degradation of the PEUR network driven by residual carboxylic acid groups can result in a mismatch in 
the rates of scaffold degradation and tissue in-growth that leads to resorption gaps and compromised 
tissue regeneration 30.  
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Approach 
To overcome the autocatalytic degradation behavior exhibited in polyester-based bone tissue 
engineering scaffolds, we propose to utilize scaffold materials whose degradation is exclusively tied to 
cellular activity. In particular, biomaterials that degrade by cell-mediated mechanisms, such as 
materials with protease-cleavable peptides, have been successfully utilized to synthesize 
environmentally-sensitive nanoparticles 31, 32, hydrogels 33, 34, and polymeric scaffolds 35, 36. However, it 
is difficult to establish this approach as a generalizable tissue engineering platform because these 
peptide sequences are cleaved by specific enzymes that are upregulated in specific pathological 
environments 37 and feature highly variable levels across patient populations 38. Also, manufacturing 
peptides on the scale necessary to fabricate large tissue scaffolds is both expensive and time-
consuming with current technology 39. Development of degradable polymers that can be affordably 
synthesized in large scales, similar to polyesters, but that target a ubiquitous cell-mediated signal for 
scaffold degradation may provide a more generalizable and better-performing biomaterial. Scaffolds 
degraded by cell-generated reactive oxygen species (ROS) are a promising candidate because ROS 
serve as important biological mediators in many normal biological processes 40, and elevated ROS, or 
“oxidative stress”, is a hallmark of inflammation and the pathogenesis of myriad diseases 41. Polymeric 
biomaterial implants have also been shown to elicit a stable three-fold increase in ROS production at 
surgery sites over a four week timeframe 42, further highlighting the potential utility of this cell-generated 
signal for triggering material degradation. This has motivated the recent emergence of new classes of 
ROS-responsive polymer-based  nanoparticles 43-48 and development of salt-leached, porous scaffolds 
composed of a combination of the polyester PCL and ROS-sensitive, proline-based peptides 49.  
Here we sought to develop a generalizable, cell-degradable polyurethane scaffold formulated 
from polyols exhibiting ROS-dependent degradation. To do so, we synthesized a new class of polyols 
based on ROS-degradable poly(thioketals) which are stable under aqueous conditions but are 
selectively degraded by cell-generated ROS. These fully synthetic, non-peptide based scaffolds have 
been developed to further explore utilization of an ROS-dependent degradation mechanism in order to 
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yield scaffolds with better matched rates of cellular infiltration and degradation to enhance repair of 
bone tissue defects (see Figure 1). 
 
Figure 1. Scheme for the formation of ROS-degradable tissue engineering scaffolds. The 
reaction between hydroxyl-functionalized PTK polymers, water, and a tri-functional isocyanate 
yields porous 3D scaffolds that are selectively degraded by cell-produced ROS. 
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CHAPTER II 
 
SYNTHESIS OF A POROUS, BIOCOMPATIBLE TISSUE ENGINEERING SCAFFOLD SELECTIVELY 
DEGRADED BY CELL-GENERATED REACTIVE OXYGEN SPECIES 
 
Introduction 
Synthetic polyester-based tissue engineering scaffolds represent a promising biomaterial 
therapy for the treatment of bone defects. In particular, in situ curing, injectable PEUR scaffolds have 
been shown to help mediate the regeneration of bone tissue in critically-sized defects25, 30, 50. PEURs 
are primarily degraded by hydrolysis, though the scission of ester bonds in the polymer chains 
generates acidic byproducts which catalyze further hydrolysis. This autocatalytic behavior can result in 
a mismatch in the rates of scaffold degradation and tissue in-growth that leads to resorption gaps and 
compromised tissue regeneration 30. To overcome this late-stage scaffold failure, materials that are 
degraded solely by cell-mediated activities have been developed. Rather than utilizing scaffolds 
comprised of synthetic peptides that are selectively cleaved by cell-generated enzymes33, 36, the most 
common methodology for achieving cell-mediated degradation, ROS-degradable scaffolds were 
developed. Nearly all the ROS-degradable materials reported to date have been applied in 
nanoparticles, with an oligo-proline peptide-based scaffold being the only currently developed ROS-
degradable tissue engineering material49. This approach for achieving scaffold biodegradation takes 
advantage of the body’s natural ROS production and is predicted to yield materials that are both more 
cost-efficient than peptide-based scaffolds while possessing a more controlled degradation profile. 
In the current study, we synthesized a new class of polyols based on ROS-degradable 
poly(thioketals) which are stable under aqueous conditions but are sensitive to oxidation. 
Poly(thioketals) (PTKs) were recently applied for development of orally-delivered nanoparticles that 
remain stable in transit through the stomach and specifically release their cargo “on demand” at sites of 
ulcerative colitis44. To date, however, this unique polymer chemistry has solely been utilized in targeted 
nanoparticle drug delivery applications44, 48. Herein, we report the development and testing of a new 
6 
 
class of PTK macrodiols amenable to synthesis of injectable, porous poly(thioketal)-urethane (PTK-UR) 
tissue engineering scaffolds that are selectively degraded by cell-generated ROS. These fully synthetic, 
non-peptide based scaffolds have been developed to further explore utilization of an ROS-dependent 
degradation mechanism in order to yield scaffolds with better matched rates of cellular infiltration and 
degradation to enhance repair of bone tissue defects. 
 
Methods 
 
Materials 
All chemicals were purchased from Sigma-Aldrich (Milwaukee, WI, USA) except the following. 2-
mercaptoethyl ether (MEE), glutaraldehyde, and cobalt chloride were purchased from Fisher Scientific 
(Pittsburgh, PA), and the tertiary amine catalyst (TEGOAMIN33) was obtained from Goldschmidt 
(Hopewell, VA).  Glycolide and D,L-lactide were obtained from Polysciences (Warrington, PA). 
Coscat83, an organobismuth urethane catalyst, was supplied by ChasChem, Inc. (Rutherford, NJ). 
Hexamethylene diisocyanate trimer (HDIt, Desmodur N3300A) was received as a gift from Bayer 
Material Science (Pittsburgh, PA). Cell culture reagents, including Dulbecco’s Modified Eagle Medium 
(DMEM), fetal bovine serum (FBS), and penicillin/streptomycin were supplied by Gibco Cell Culture 
(Carlsbad, CA). All materials were used as received unless otherwise indicated. 
 
PTK Dithiol Synthesis 
The condensation polymerization protocol for PTK prepolymer synthesis was adapted from 
Wilson et al.44. Briefly, p-toluenesulphonic acid monohydrate (PTSA) was added to a tri-necked boiling 
flask equipped with an attached addition funnel. The vessels were placed under vacuum for 15 min 
before being purged with nitrogen. The boiling flask was charged with anhydrous acetonitrile and batch-
specific amounts of MEE (x molar eq) and 1,4 butanedithiol (BDT) (1-x molar eq) where x = 1, 0.75, 
0.5, 0.25, and 0 for the synthesized PTKs, respectively. The addition funnel was also charged with 
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anhydrous acetonitrile and 2,2-dimethoxypropane (DMP) (0.83 molar eq). A molar excess of dithiol 
monomers was utilized relative to DMP to ensure the formation of polymers with free terminal thiols. 
Both the addition funnel and boiling flask’s solutions were purged with flowing nitrogen for 30 min 
before submerging the boiling flask into an oil bath at 80°C. After 15 min of temperature equilibration, 
the addition funnel stopcock was set so that the acetonitrile-DMP solution was added drop-wise into the 
continuously stirring boiling flask over a period of 16 h. Post synthesis, the acetonitrile was removed by 
rotary evaporation and the resultant PTKs were isolated by precipitation into cold ethanol and dried 
under vacuum. To evaluate polymer compositions, samples of the respective PTKs were dissolved in 
deuterated chloroform (CDCl3) and analyzed with 1H nuclear magnetic resonance spectroscopy (NMR, 
Bruker 400 MHz Spectrometer). 1H NMR chemical shifts were reported as δ values in ppm relative to 
the deuterated CDCl3 (δ = 7.26). Multiplicities are reported as follows: s (singlet), d (doublet), t (triplet), 
and m (multiplet). The number of protons (n) for a given resonance is indicated as nH and is based on 
integration values. 1H NMR (400 MHz, CDCl3): δ = 3.67-3.61 (m, 4H), δ = 2.83 (t, 4H), δ = 2.63 (t, 4H), 
δ = 1.72 (t, 4H), δ = 1.60 (s, 6H). 
 
Polyester Polyol Synthesis 
Trifunctional or bifunctional polyester polyols were synthesized as previously documented18.  To 
synthesize the trifunctional polyol, glycerol was vacuum dried for 48 h at 80oC and then added to a 100 
mL three neck flask. By molar amount, 60% ε-caprolactone, 30% glycolide, and 10% D,L-lactide were 
added to the glycerol starter along with a stannous octoate catalyst to yield a 900 g mol-1 triol, a 1000 g 
mol-1 diol, and a 1500 g mol-1 triol.  
 
PTK Hydroxyl Functionalization 
The hydroxyl-functionalization of the PTK dithiols was completed51 in order to generate polyols 
compatible with standard polyurethane synthesis. Briefly, PTK dithiol polymers were transferred to a 
boiling flask, placed under vacuum, and then exposed to a nitrogen atmosphere. The flask was charged 
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with anhydrous dichloromethane (DCM) before adding a 10x molar excess of β-mercaptoethanol to the 
solution. This solution was stirred continuously at room temperature to reduce any disulfide bonds and 
recover the reactive thiol end groups. After 3 h of stirring, the DCM was evaporated and the residue 
was washed three times in cold ethanol to remove residual β-mercaptoethanol. The reduced PTK 
polymers were dissolved in anhydrous tetrahydrofuran (THF) before adding a 10x molar excess of 
cesium carbonate (CsCO3) under nitrogen and stirring for 30 min at room temperature. A 5x molar 
excess of 2-bromoethanol was next added to the solution and stirred for 18 hours under nitrogen at 
room temperature. After stirring, the solution was added to a separation funnel with an excess of 
deionized water to effectively separate the PTK-solubilizing THF layer from the water-soluble CsCO3 
catalyst. The hydroxyl-functionalized PTKs were extracted in THF before removing the solvent by rotary 
evaporation, followed by precipitation three times in cold ethanol before vacuum drying for 24 h. 
Molecular weights and polydispersities of the five synthesized PTK diols were analyzed by gel 
permeation chromatography (GPC, Agilent Technologies, Santa Clara, CA) using a mobile phase of 
N,N-dimethylformamide (DMF) with 100mM LiBr. Polymer molecular weights were quantified using a 
calibration curve generated from poly(ethylene glycol) (PEG) standards (400 – 4000 g mol-1). Hydroxyl-
functionalization was confirmed by 1H NMR (400 MHz, CDCl3): δ = 2.74 (t, 4H) and attenuated total 
reflectance Fourier transform infrared spectroscopy (ATR-FTIR; Bruker Tensor 27 FTIR, Billerica, MA). 
For ATR-FTIR, thiol-terminated and hydroxyl-terminated PTK polymers were placed in contact with a 
ZnSe ATR crystal to quantify absorbance at 2550 cm-1 and 3400 cm-1, which correspond to absorbance 
peaks of free thiol and free hydroxyl groups, respectively. The hydroxyl (OH) numbers of the different 
PTK diols were determined by titration (Metrohm 798  MPT Titrino, Herisan, Switzerland) according to 
ASTM E1899 – 08 52. Eq (1) was used to relate the molecular weight to the hydroxyl number of each 
titrated PTK: 
𝑴𝒏 =  𝟓𝟔𝟏𝟎𝟎𝒇𝑶𝑯 𝒏𝒖𝒎𝒃𝒆𝒓 (1) 
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where 56,100 represents the molecular weight of KOH in mg/mol, f represents the hydroxyl functionality 
of the PTK (assumed to be 2 for the linear homobifunctional polymers in this study), and Mn represents 
the number-average molecular weight of the polymer. 
 
PTK-UR and PEUR Synthesis 
The PTK-UR and PEUR scaffolds were prepared using two-component reactive liquid molding of: 
(a) hexamethylene diisocyanate trimer (HDIt), and (b) a hardener component comprising the PTK diol, 
0.5 – 1.5 parts per hundred parts polyol (pphp) water, 10.0 pphp TEGOAMIN33 catalyst, 0.5 – 3.0 pphp 
sulfated castor oil stabilizer, and 4.0 pphp calcium stearate pore opener 18. The makeup of the hardener 
components for the different respective PTK diols was individually optimized to yield scaffolds with 
mechanical integrity and an intact porous structure. PEUR scaffolds were respectively designated by 
their polyester precursor as 900t-PEUR, 1000d-PEUR, and 1500t-PEUR and served as hydrolytically-
degradable controls. The hardener component elements were first mixed for 30 s at 3300 rpm in a 
Hauschild DAC 150 FVZ-K SpeedMixer (FlackTek, Inc., Landrum, SC) before adding the HDIt and 
mixing for an additional 30 s. This reactive liquid mixture was allowed to rise freely for 10-20 min for 
complete setting and hardening. The targeted index (ratio of NCO to OH equivalents times 100) was 
115, where the number of OH equivalents is calculated from the experimentally measured OH number 
for the relevant PTK diol. 
 
Characterization of Scaffold Physical Properties  
The core densities of PTK-UR and PEUR scaffolds were determined by measuring the mass and 
volume of cylindrical porous scaffold core samples, with the core porosities being subsequently 
calculated from these density values18. The porous morphologies of the different PTK-UR scaffolds 
were qualitatively assessed by scanning electron microscopy (Hitachi S-4200 SEM, Finchampstead, 
UK). The amount of unreacted components (sol fraction) in the cross-linked network was measured 
from the mass loss of dried scaffold cylinders (25 mm × 12 mm) previously incubated in DCM for 24 h. 
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To measure the molecular weight between crosslinks (Mc), scaffold samples (n = 3) were weighed dry 
and then incubated in DCM for 24 h. After incubation, samples were gently blotted to remove excess 
DCM and then the samples’ swollen mass was measured. These values, along with the solvent 
parameters, were used in the Flory-Rhener equation to determine Mc. For measuring scaffold 
hydrophilicity, PTK-UR films of 100%, 50%, and 0% MEE-PTK diols were synthesized using an index of 
105 and the gelling catalyst Coscat83 at 1000 ppm. After mixing the catalyst and PTK diol for 30 s at 
3300 rpm, HDIt was added and mixed for an additional 30 s. The mixtures were cast into Teflon 
compression molds and allowed to cure for 18 h at 60°C. The contact angle of water on these PTK-UR 
films was measured using a Rame-Hart (Mountain Lakes, NJ) Model A-100 contact angle goniometer. 
A 4 μL water drop was added to the film surface, and after 10 min, an equilibrium contact angle was 
measured to account for molecular surface reorganization which increased the hydrophilicity at the 
contact site53. 
 
Thermal and Mechanical Properties 
Thermal transitions were measured by a TA Instruments (New Castle, DE) Q200 DSC and Q800 
DMA.  For DSC analysis, samples ranging in mass from 10-15 mg were heated from -80o C to 200o C at 
a rate of 10o C min-1, cooled to -80o C at a rate of -20o C min-1, and heated a second time to 200o C at a 
rate of 10o C min-1.  All transitions were obtained from the second heating run.  For dynamic mechanical 
analysis (DMA, Q800 DMA, TA Instruments, New Castle, DE), cylindrical samples (6 × 6 mm) were 
analyzed from -80o to 55o C at a ramp rate of 1o C min-1.  Scaffolds were compressed at a frequency of 
1 Hz with 1% strain during the thermal treatment.  Glass transitions were obtained at the peak of tan δ. 
The mechanical properties of the different PTK-UR and PEUR scaffold formulations were 
measured in compression at 37°C in a submersion compression clamp using the Q800 DMA. 
Cylindrical 6 × 6 mm scaffold samples were tested after incubation in phosphate buffered saline (PBS) 
for 7 days at 37°C. Using a preload force of 0.1 N, samples were compressed along the longitudinal 
axis at a strain rate of 10% per min until 60% compressive strain was achieved. The Young’s modulus 
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for each sample was calculated from the slope of the initial linear region of each respective stress-strain 
curve after toe-in.  
 
In Vitro Degradation of PTK-UR and PEUR Scaffolds 
Long-term hydrolytic stability of PTK-UR and PEUR scaffolds was determined by incubating 10 
mg samples in PBS at 37°C on a shaker and measuring the mass loss at each time point (n = 3). 
Before beginning the experiment, scaffolds were soaked in an excess of DCM for 24 h to remove any 
unreacted components before vacuum drying for 24 h. Scaffold samples were removed from the buffer 
at each time point, rinsed in deionized water, vacuum dried for 48 h, and weighed. The buffer medium 
was not changed between time points. Short term oxidative degradation rates of PTK-UR scaffolds 
were similarly assessed using an oxidative degradation medium that simulates in vivo oxidative 
degradation at an accelerated rate54, 55. This oxidative medium comprised 20 wt% hydrogen peroxide 
(H2O2) in 0.1 M cobalt chloride (CoCl2), with the H2O2 and cobalt ion reacting to stimulate oxidative 
radical formation 54.  As with the long-term study, triplicate samples were pre-soaked in DCM for 24 h 
before vacuum drying and incubated at 37°C in the oxidative medium on a shaker. At specified time 
points over 10 d, samples were removed, rinsed with deionized water, vacuum dried, and weighed. The 
oxidative medium was replaced every 3 days, and the morphology of both PBS-incubated and H2O2-
incubated scaffolds was qualitatively assessed with SEM. 
The effect of radical concentration on PTK-UR scaffold degradation kinetics was also explored. 
The original 20% H2O2 in 0.1 M CoCl2 degradation medium was diluted ten and one hundred fold to 
yield a 2% H2O2 in 0.01 M CoCl2 solution and a 0.2% H2O2 in 0.001 M CoCl2 solution. These three 
degradation media were used to incubate 100%, 50%, and 0% MEE-PTK-UR scaffolds along with 900t-
PEUR control samples, with material preparation steps and incubation conditions being the same as 
previously described.  
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Mathematical Modeling of PTK-UR Oxidative Degradation 
The degradation behavior of the PTK-UR scaffold formulations were fit to first-order decay kinetics 
equation to create a mathematical model of scaffold degradation with respect to H2O2 concentration. 
The first-order degradation model is given in Eq 2. 
𝑴𝒕
𝑴𝟎
� = 𝒆−𝒌𝒕 (1) 
In this equation, Mt is the scaffold mass remaining at time t, M0 is the initial scaffold mass, and k is the 
degradation rate constant. Non-linear regression was used to fit this first-order degradation model to 
the experimentally determined degradation data. This method was used to determine the degradation 
rate constant k for the scaffolds incubated in the different media. 
 
In Vitro Culture of Macrophages on PTK-UR Scaffolds 
RAW 264.7 macrophages were cultured in DMEM supplemented with 10% FBS and 1% 
penicillin/streptomycin. 100% and 0% MEE-PTK-UR scaffolds were cut into 6.5 × 1-mm discs, sterilized 
by UV-radiation for 1 h (30 min per side), placed into 96-well plates, and incubated with culture medium 
for 30 min. Macrophages were seeded onto the scaffolds at a density of 2.5 × 105 cells/scaffold. The 
cells were allowed to adhere to the scaffolds for 3 h, at which point the media were removed and the 
cells were treated with either fresh culture media or activation media containing 5 μg mL-1 
lipopolysaccharide (LPS) and 1000 U mL-1 interferon gamma (IFN-γ). Cells were incubated on the 
scaffolds for 3 d with fresh culture media being applied daily. After the 3 d incubation, the scaffolds 
were fixed in 5% glutaraldehyde for 2 h followed by 2% osmium tetroxide for 1 h. These fixed scaffolds 
were dehydrated in ascending grades of ethanol before being vacuum dried, sputter-coated, and 
imaged with SEM to evaluate surface pitting. 
 
 
 
13 
 
Cytotoxicity of PTK-UR and PEUR Scaffolds 
NIH 3T3 mouse fibroblasts stably transfected with a firefly luciferase reporter gene were cultured 
in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin. 100% MEE-PTK-UR, 0% MEE-
PTK-UR, and 900t-PEUR scaffolds were cut into 6.5 × 1-mm discs, sterilized by UV-radiation for 1 h 
(30 min per side), placed into a black-walled 96-well plate, and incubated with culture medium for 30 
min. Fibroblasts were seeded at a density of 5.0 × 104 cells/scaffold on n=3 scaffolds and allowed to 
grow for 0, 1, and 3 days in 200 μL of culture media per well (changed every two days). At the 
endpoint, the cell-seeded scaffolds were treated with culture media containing a luciferin substrate. 
After 10 min, the scaffolds were imaged with an IVIS 200 (Xenogen, Alameda, CA) bioluminescence 
imaging system with an exposure time of 2 min to quantify the luciferase-based bioluminescence signal 
from each scaffold’s viable cell population.  All readings were normalized to day 0 bioluminescence 
values. 
 
In Vivo Degradation of PTK-UR Scaffolds Implanted Subcutaneously in Rats 
All surgical procedures were reviewed and approved by Vanderbilt University’s Institutional 
Animal Care and Use Committee. 100% MEE-PTK-UR, 0% MEE-PTK-UR, and 900t-PEUR scaffolds 
were cut into 10 × 2.5 mm discs, sterilized with ethylene oxide, and implanted into ventral 
subcutaneous sites in adult male Sprague-Dawley rats. Scaffolds were excised from euthanized 
animals at weeks 1, 3, 5 and 7 to evaluate new granulation tissue formation in the implants. The 
excised tissues were fixed in formalin, processed, sectioned, and stained with hematoxylin & eosin. 
Histological sections were evaluated with Metamorph Imaging Software (Molecular Devices Inc., 
Sunnyvale CA) to assess wound dimensions and scaffold degradation. The wound area was defined as 
the cross-sectional area occupied by the scaffold and new tissue growth. Values for the percentage of 
scaffold area occupying the wound area were normalized to week 1 values to eliminate the effect of 
scaffold compression over time, and 100% MEE-PTK-UR degradation was fit to the first-order 
degradation kinetics model seen in Eq. 2. 
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Statistical Analysis 
All data are reported as the mean and standard error of the mean unless otherwise indicated. 
Statistical analysis was performed using single factor analysis of variance (ANOVA) and Tukey post-
hoc comparison tests, with p-values less than 0.05 considered statistically significant. 
 
Results 
 
PTK Polymer Synthesis and Characterization 
Thiol-terminated PTK polymers were successfully synthesized from the condensation 
polymerization of MEE, BDT, and DMP monomers using PTSA as a catalyst (Figure 2A). Five 
copolymers were synthesized with varying percent molar composition of MEE and BDT, and each 
polymer is designated by its relative mol% MEE. 1H-NMR spectra confirmed that the composition of the 
synthesized polymers closely matched the monomer ratios in the feed (Figure 2B, Table 1), and gel 
permeation chromatography (GPC) analysis showed that the polymers had Mn values of around 1000 g 
mol-1 with polydispersity index (PDI) values near 1.35 (Figure S1, Table 1).  
Efficient conversion of terminal thiols to hydroxyls was demonstrated by ATR-FTIR. The thiol 
absorbance peak at 2550 cm-1 was apparent in the thiol-terminated, parent PTKs but did not appear 
with the hydroxyl-terminated polymers, which generated a characteristic ATR-FTIR hydroxyl peak at 
3400 cm-1 (Figure 2C). OH numbers experimentally measured with titration were utilized to calculate a 
titration Mn (Table 1) that was used to balance the hydroxyl-isocyanate reaction used to form PTK-URs. 
Consistent with previous findings, the experimental OH numbers trended higher than theoretical 
values23.  
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Figure 2. Synthesis and characterization of a family of PTK diols. (A) Scheme for the condensation 
polymerization of thiol-terminated PTKs and their conversion into PTK diols. (B) 1H-NMR spectra of the 
PTK copolymer diols.  Peaks associated with MEE and BDT monomers correlated with molar composition 
used in the polymer feed. (C) ATR-FTIR spectra of thiol- and hydroxyl-terminated PTKs. The thiol 
absorbance peak is seen at 2550 cm-1 (black arrow) and the hydroxyl absorbance peak is seen at 3400 
cm-1 (grey arrow). These spectra demonstrate efficient conversion of PTK terminal thiols into hydroxyls. 
 
 
 
 
 
 
 
 
 
 
Table 1. Characterization of PTK diols. 
Copolymer 
(PTK diol) 
Feed 
MEE% 
Actual 
MEE%a 
GPC 
Mnb PDI
b Titration 
Mnc 
100%  
MEE-PTK 100% 100% 1027 1.38 825 
75%  
MEE-PTK 75% 76% 1005 1.34 850 
50%  
MEE-PTK 50% 52% 947 1.35 810 
25%  
MEE-PTK 25% 26% 1053 1.36 745 
0%  
MEE-PTK 0% 0% 807 1.32 680 
aCalculated from NMR peaks at δ=1.72 and δ=3.64 ppm. 
bCalculated from GPC standards. 
cCalculated from measured titration OH numbers. 
A B 
C 
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PTK-UR Scaffold Formation and Physical Properties 
PTK-UR scaffolds were successfully synthesized from the PTK diols and HDIt, yielding porous, 
mechanically robust 3D scaffolds (SEM images shown in Figure S2). PEUR control scaffolds were also 
successfully formed from HDIt and the three different polyester prepolymers (1000d, 1500t, and 900t). 
The resulting PTK-UR and PEUR scaffolds possessed similar sol fraction and porosity, as seen in 
Table 2.  The average molecular weight between crosslinks (Mc) for 1000d- and 1500t-PEUR was 
statistically equal to all of the PTK-UR scaffolds, while the 900t-PEURs had a significantly lower Mc (p < 
0.05) relative to all other formulations except for the 100% and 0% MEE-PTK-UR scaffolds (Table 2). 
The relative surface hydrophilicity of the PTK-UR materials was assessed using contact angle 
measurements on films, with 100%, 50%, and 0% MEE-PTK-URs having contact angle values of 66°, 
77°, and 80°, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Physical properties of PTK-UR and PEUR 
scaffolds.  
Scaffold Sol Fraction (%) 
Core 
Porosity 
(vol. %) 
Mc  
(kg mol-1) 
100% MEE 
PTK-UR 6.9%±1.6% 90.9%±0.4% 7.6±4.2 
75% MEE 
PTK-UR 8.4%±1.4% 89.0%±1.2% 10.1±4.9 
50% MEE 
PTK-UR 9.7%±6.1% 86.9%±1.4% 13.8±6.5 
25% MEE 
PTK-UR 9.1%±2.7% 90.6%±1.5% 9.0±5.0 
0% MEE 
PTK-UR 8.3%±3.2% 88.8%±1.4% 9.0±5.8 
900t 
PEUR 4.1%±1.6% 89.8%±1.2% 2.5±1.6 
1500t 
PEUR 4.7%±0.1% 91.3%±0.2% 13.2±5.4 
1000d 
PEUR 7.7%±0.1% 92.7%±0.7% 7.7±2.8 
*All values presented as mean ± standard deviation 
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Thermal and Mechanical Analysis of PTK-UR Scaffolds 
The glass-transition temperature (Tg) of PTK polyols was determined by differential scanning 
calorimetry (DSC), and the Tg of the PTK-UR scaffolds was measured by DSC and dynamic 
mechanical analysis (DMA) (Table S1). The wet compressive moduli of the PTK-UR scaffolds ranged 
from 100 - 250 kPa, and the PEUR moduli ranged from 20 – 100 kPa (Figure 3). All the PTK-UR 
formulations had significantly higher modulus values than the 1500t-PEUR and 1000d-PEUR materials, 
while the lower Mc 900t-PEUR scaffolds possessed stiffness values closer to the PTK-UR samples. 
However, even this formulation was significantly less stiff than the 100% and 0% MEE-PTK-UR 
materials. 
 
Figure 3. PTK-UR and PEUR scaffold mechanical properties. The compressive moduli of porous 
scaffolds were determined under fully hydrated conditions at 37°C. *p < 0.05 compared to 1500t- and 
1000d-PEUR. #p < 0.05 compared to 900t-PEUR. 
 
In Vitro Degradation of PTK-UR Scaffolds under Aqueous and Oxidative Conditions 
The hypothesized oxidative degradation mechanism of PTK copolymers is seen in Figure 4. 
Qualitative PTK-UR degradation was demonstrated by SEM as scaffolds incubated for 10 d in oxidative 
media illustrated loss of porous architecture and surface pitting, while these morphological changes in 
scaffold architecture were not apparent following PTK-UR scaffold incubation in PBS for 25 weeks 
18 
 
(Figure 5A and S2). The PTK-UR scaffolds were stable over a long-term, 25-week study in PBS at 
37°C, while the 900t-PEUR scaffolds underwent significant hydrolytic degradation over this time period 
(Figure 5B). Conversely, the PTK-URs rapidly degraded under accelerated oxidative conditions (20% 
H2O2 in 0.1 M CoCl2) as seen in Figure 5C. The degradation profiles of all PTK-UR formulations in the 
20% H2O2 media are seen in Figure S3.   
 
Figure 4. Proposed mechanism for hydroxyl radical degradation of PTK polymers. 
 
Mathematical Model of ROS-Dependent PTK-UR Scaffold Degradation 
To further elucidate the relationship between ROS concentration and the degradation rates of the 
different PTK-UR scaffold formulations, degradation was measured in oxidative media comprising 20%, 
2%, and 0.2% H2O2 and 0.1, 0.01, and 0.001 M CoCl2, respectively.  The degradation rates of PTK-UR 
scaffolds were dependent on the concentration of H2O2 (Figure 5D-G). The mass loss profiles of the 
PTK-UR scaffolds were fit to first-order degradation kinetics (Eq. 2) to mathematically model the 
process of scaffold degradation with respect to H2O2 concentration. The model-generated degradation 
profiles are concurrently shown with the respective experimental data as dotted lines in Figure 5C-F, 
with the derived degradation rate constants being shown in Figure 5G. The 900t-PEUR samples 
incubated in these same oxidative media did not display significant degradation over the same time 
scale (Figure 5G and S4). 
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Figure 5. In vitro degradation of PTK-UR scaffolds. Data are presented as mean ± standard error with n = 3.   
(A) SEM of PTK-UR scaffolds: freshly made (left column), incubated in PBS for 25 weeks (middle column), and 
incubated in 20% H2O2 media for 10 d (right column). Scale bars = 231 μm. The ROS-degraded scaffolds feature 
irregular pore morphology and surface pitting.  (B) Long-term stability of PTK-UR scaffolds incubated in PBS. (C) 
Percent degradation of PTK-UR scaffolds incubated in oxidative medium (20% H2O2 in 0.1M CoCl2). Dashed lines 
represent model-generated curves for first-order degradation kinetics, *p < 0.05. Percent mass remaining of (D) 
100% MEE-PTK-UR, (E) 50% MEE-PTK-UR, and (F) 0% MEE-PTK-UR scaffolds incubated in oxidative media 
containing 20%, 2%, and 0.2% H2O2. (G) Degradation constants used to generate the best-fit curves in (C-F), as 
determined by non-linear regression analysis. The PTK-UR but not the PEUR scaffolds exhibited H2O2 dose-
dependent degradation. 
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In Vitro Cell-Mediated Degradation and Cytocompatibility of PTK-UR Scaffolds 
100% and 0% MEE-PTK-UR scaffolds were seeded with murine-derived RAW 267.4 
macrophages. Seeded cells were treated with either control culture media or macrophage-activating 
media containing LPS and IFN-γ.  SEM imaging of scaffolds after three days illustrated surface pitting 
by activated macrophages, but cell mediated scaffold degradation was not apparent for the control cells 
(Figure 6A). 
NIH 3T3 mouse fibroblasts stably transduced to express luciferase were seeded onto 100% MEE-
PTK-UR, 0% MEE-PTK-UR, and 900t-PEUR scaffolds, and relative cell number was measured based 
on luciferase activity over 3 days of culture (Figure 6B). Cell-generated bioluminescent signal was 
steadily maintained over the culture period, and there were no significant differences between the 
scaffold compositions tested.    
 
Figure 6. In vitro cell-mediated degradation and cytocompatibility of PTK-UR scaffolds. (A) PTK-UR 
scaffolds seeded with RAW 267.4 macrophages and incubated for 3 d in either control or activation media (LPS 
and IFN-γ). The activated macrophages generated visible pitting on the scaffold surface (black arrows), indicating 
ROS-mediated scaffold degradation. Scale bar = 20 μm. (B) In vitro biocompatibility of porous 3D PTK-UR 
scaffolds.  The bioluminescence (cellular viability) from 3T3 fibroblast-seeded scaffolds was normalized to day 0 
values and remained stable over 3 d in culture. 
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In Vivo Degradation of PTK-UR Scaffolds in a Rat Subcutaneous Wound Model 
100% MEE-PTK-UR and 900t-PEUR scaffolds subcutaneously implanted into male Sprague-
Dawley rats demonstrated robust cellular infiltration, a minimal inflammatory response, and granulation 
tissue formation by 3 weeks post implantation (Figure 7A). The 0% MEE-PTK-UR materials also 
provoked a minimal inflammatory response from the native tissue but supported visibly less tissue in-
growth and were thus not quantitatively analyzed. Both the 100% MEE-PTK-UR and 900t-PEUR 
materials displayed significant degradation over 7 weeks (Figure 7B). However, the 100% MEE-PTK-
UR implants followed first-order degradation kinetics (dashed line, Figure 7B) and degraded gradually 
over 7 weeks to reach 40% degradation, whereas at their end point the 900t-PEUR scaffolds were 75% 
degraded compared to week 1 values, and degradation initialized after week 3. The 900t-PEUR 
scaffolds were also significantly more compressed than the PTK-UR materials, which stented the 
implant site significantly more than the PEUR scaffolds (Figure 7C). Wound lengths were relatively 
consistent between PTK-UR and PEUR implant sites over time, while wound area measurements 
followed trends similar to the scaffold thickness values (Figures S5 and S6). 
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Figure 7. In vivo response of  subcutaneous PTK-UR scaffolds. (A) Histological illustration of cellular 
infiltration into PTK-UR and control PEUR scaffolds (designated with S in the Week 5 High Magnification panels) 
in Sprague-Dawley rats. The 0% MEE-PTK-UR formulation did not support new tissue in-growth over 5 weeks. 
(B) In vivo scaffold degradation normalized to week 1. Though initially 90% porous, the PEURs became 
compressed and experienced rapid late-stage break down in comparison to the slowly degrading PTK-URs which 
follow first-order degradation kinetics (dashed line represents model-generated curve). §p < 0.05 compared to 
week 1, #p < 0.05 compared to week 3, $p < 0.05 compared to week 5. (C) Compression of PTK-UR vs. PEUR 
scaffolds. The PTK-UR scaffolds maintained their mechanical integrity/thickness and provided a grea ter stenting 
effect than the PEUR implants, *p < 0.05. 
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Discussion 
Many currently utilized tissue engineering scaffolds feature hydrolytically degradable ester bonds 
that nonspecifically break down in the presence of water. Cleavage of ester bonds produces free 
carboxylic acids which can acidify the local microenvironment and cause autocatalytic degradation28, 
leading to reduced tissue regeneration30. Here, a novel PTK-based scaffold technology is presented 
that is specifically degraded by cell-generated ROS while remaining insensitive to hydrolysis (Figure 
5B)44. Because these PTK-UR materials selectively degrade by cell-mediated activity, they avoid 
autocatalytic degradation and are anticipated to yield better matched rates of cellular infiltration and 
scaffold degradation. To this end, PTK copolymers were successfully synthesized with varying chain 
compositions but similar Mn and PDI values (Figure 2, Table 1). The resulting dithiol-terminated MEE-
PTK polymers were converted into diols to generate telechelic end groups compatible with standard 
polyurethane synthesis and to provide PTK polyols amenable to direct comparison with polyesters used 
in PEUR scaffold formation.   
The PTK-UR scaffolds were fabricated using HDIt and compared to PEUR scaffolds made from 
900t, 1000d, and 1500t polyester-based PEUR scaffolds. The 900t-PEUR represented a biological 
control that has been successfully used for in vivo applications24, 56, 57 while the 1000d-PEUR and 
1500t-PEUR were synthesized for a more direct material comparison to the PTK-URs because they 
yield PEUR scaffolds with similar crosslink densities to the PTK-UR scaffolds. The PTK-UR scaffolds 
produced from the PTK macrodiols were approximately 90% porous and were morphologically similar 
to more conventional PEUR 3D porous scaffolds.  This level of porosity is optimal for promoting cellular 
in-growth, nutrient exchange, and neo-vascularization in tissue engineering applications58-60. The PTK-
URs also featured relatively low sol fraction values, indicating that the isocyanates and diols were well 
matched and efficiently reacted during scaffold formation. As expected, the scaffolds’ relative 
hydrophilicity was influenced by the composition of the PTK polyol, and the contact angle was inversely 
correlated with the mol% of the more hydrophilic MEE monomer in the PTK copolymer. These data 
suggest that the 100% MEE-PTK-UR with a contact angle of 66° may be optimal for cellular adhesion 
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and tissue formation in vivo, since more hydrophobic surfaces with contact angles > 76° (such as the 
50% and 0% MEE-PTK-UR formulations) preferentially adsorb hydrophobic serum proteins such as 
albumin over cellular adhesion proteins like fibronectin and vitronectin61, 62. 
Thermal analysis of PTK-UR and PEUR scaffolds, along with their polymeric precursors, indicated 
that the scaffolds are phase-mixed materials since the 3D materials all possessed a Tg exceeding that 
of the polyol precursor soft segment23. The scaffold Tg values determined by DMA also exceeded those 
measured by DSC by 30 – 50°C, as has been previously reported for similar 3D PEUR materials18. Wet 
compression testing of these materials indicated that although the 1500t-PEUR, 1000d-PEUR, and 
PTK-UR scaffolds had similar Mc values (Table 2), all of the PTK-UR formulations had significantly 
higher modulus values than the 1500t-PEUR and 1000d-PEUR materials (Figure 3). However, there 
was no consistent trend between PTK-UR scaffold composition and modulus. Due to its higher 
crosslink density, the 900t-PEUR achieved stiffness values closer to the PTK-UR samples, though even 
this formulation was significantly less stiff than the 100% and 0% MEE-PTK-UR materials.  
Previous work has demonstrated the selective, ROS-mediated degradation of poly(thioketal) 
nanoparticles44. The PTK-UR scaffolds were formulated with HDIt because it is more oxidatively stable 
relative to lysing-derived isocyanates22, 24, 56, allowing more specific study of the degradation behavior of 
the polyol component. Degradation of PTK-UR and 900t-PEUR scaffolds was tested in an oxidative 
degradation medium comprising H2O2 and CoCl2 that produces hydroxyl radicals54. These radicals 
destabilize the thioketal bond, leading to chain scission and breakdown into the original constitutive 
monomers (MEE and BDT) and acetone (Figure 4). It is predicted that these small byproducts would 
be rapidly cleared in an in vivo environment. Furthermore, these thiolated monomers have been shown 
to cause limited in vitro cytotoxicity63 and a minimal host inflammatory response in vivo64 when 
incorporated into a similar polyurethane system.  
The long-term stability of PTK-UR scaffolds over 25 weeks in PBS (Figure 5B) is significantly 
different than these materials’ rapid degradation under accelerated oxidative conditions as seen in 
Figure 5C, highlighting the ROS-specific degradation mechanism of the PTK-UR scaffolds. 
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Furthermore, there was a relationship between the PTK composition and degradation rate, as the 
scaffolds with higher MEE content in the PTK polyol degraded faster (Figure 5C). It has been 
previously reported that ethers are stable in aqueous media but that oxidative radicals can degrade 
them in vitro and in vivo 54. Thus, it is hypothesized that the faster ROS-dependent degradation seen in 
both the 100% and 50% MEE-PTK-UR materials may result from a  combination of oxidative 
degradation of both thioketals and ethers, while the 0% MEE-PTK-UR scaffolds are degraded solely by 
thioketal scission. These results indicate that ROS-dependent scaffold degradation rates can be tuned 
by the composition of the PTK polyol.  
For all PTK-UR compositions tested, the degradation rate was dependent on ROS concentrations 
(Figure 5D-F). This dose-dependent relationship between ROS levels and degradation rate coupled 
with the agreement between the model and experimental data confirm that the PTK-UR scaffolds 
degrade by first-order kinetics with respect to ROS concentration. The degradation rate constants 
derived from the non-linear regression fitting of the experimental data gathered in 20% H2O2 media 
(Figure 5G) also illustrate the relationship between degradation rate and the %MEE-PTK polyol used in 
PTK-UR scaffold fabrication, though this trend was decreased under lower H2O2 concentrations. In 
contrast, the 900t-PEUR samples incubated in these same oxidative media did not display H2O2 dose-
dependent degradation (Figure 5G and S4), highlighting the unique degradation mechanism of the 
PTK-UR relative to PEUR scaffolds. These collective data confirm that PTK-based polyols are 
selectively cleaved by ROS and that their rate of degradation is first-order with respect to the 
concentration of radical species in the local environment.  
PTK-UR scaffolds were shown to display a high level of in vitro cytocompatibility with both RAW 
267.4 macrophages and NIH 3T3 fibroblasts. Seeded macrophages were treated with either control 
culture media or media containing LPS and IFN-γ to activate the macrophages through the classical 
pathway65, 66, which is known to lead to ROS production24, 49. Scaffolds with activated macrophages 
displayed enhanced surface pitting while cell-mediated remodeling of the scaffold surface was less 
evident for the control cells (Figure 6A), indicating that the PTK-UR scaffolds were degraded by 
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physiologically relevant concentrations of ROS. Further highlighting these materials’ cytocompatibility, 
luciferase-expressing fibroblasts seeded on PTK-UR and PEUR scaffolds steadily maintained their 
bioluminescent signal over the culture period (Figure 6B), similar to cell growth profiles seen in other 
biocompatible 3D scaffolds67, 68. Similar cell lines stably transduced to express luciferase have been 
previously used to reliably measure in vitro cytocompatibility, as their constitutive luciferase activity 
directly correlates with cell number31. Furthermore, none of the scaffold formulations displayed a 
significant difference in bioluminescence over time or relative to each other, indicating that PTK-UR 
scaffolds possessed biocompatibility levels analogous to PEUR scaffolds that are cytocompatible and 
have been successfully utilized in vivo 24. 
This in vivo cytocompatibility was confirmed by histological analysis of subcutaneous implants, 
which showed that neither the 100% nor 0% MEE-PTK-UR formulations elicited an inflammatory 
response from the native tissue that was obviously different from the conventional PEUR scaffolds 
(Figure 7A). However, the 0% MEE-PTK-UR scaffolds supported much less robust tissue infiltration 
into the scaffold interior relative to the 100% MEE-PTK-UR or 900t-PEUR scaffolds. One possible 
explanation for this result is that the relative hydrophobicity of the 0% MEE-PTK-UR scaffolds (80° 
contact angle) did not allow cells to properly adhere and migrate into the scaffold interior. As a result, 
only the 100% MEE-PTK-UR and 900t-PEUR histology samples were quantitatively analyzed. Both 
these formulations supported new tissue growth into the scaffold interior 3 weeks after implantation and 
displayed significant biodegradation over 7 weeks (Figure 7B). The 900t-PEURs experienced a steep 
increase in degradation after 3 weeks as expected from previous work with these materials24, while the 
100% MEE-PTK-UR scaffolds displayed first-order degradation over time. This finding confirms the 
initial hypothesis that PTK-UR scaffolds degrade by a cell-mediated mechanism compared to hydrolytic 
degradation of more conventional PEUR materials, which have been recently shown to undergo to 
autocatalytic degradation in vivo resulting in a reduced wound healing response30. Furthermore, the 
PTK-UR samples were more mechanically resilient and were more effective in maintaining implant 
geometry as seen in Figure 7A and C. Though all scaffolds initially possessed 90% porosity and were 
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cut to the same dimensions pre-implantation, the PEUR materials were significantly more compressed 
than the PTK-UR scaffolds by week 1. As the wound length was relatively consistent between PTK-UR 
and PEUR scaffolds (Figure S5), the total wound area values closely mirrored the trends seen in the 
scaffold thickness measurements (Figure S6). This in vivo compression of PEUR scaffolds can be 
potentially attributed to both the significantly higher modulus of the 100% MEE-PTK-UR samples 
relative to the 900t-PEUR formulation (Figure 3), and also to the 900t-PEUR Tg value (34.4 °C) which 
is close to body temperature (Table S1). This relatively high Tg predicts a less mechanically resilient 
PEUR scaffold at body temperature because it would be in its glassy transition viscoelastic region. The 
stenting effect seen in these PTK-UR scaffolds is advantageous because it ensures that the scaffold 
pores remain open, maximizing cell infiltration and new tissue formation and potentially decreasing 
scarring in clinical applications 69. 
 
Conclusions 
ROS are key mediators of cell function in both health and disease, especially at sites of 
inflammation and tissue healing. Utilizing these cell-generated species as triggers for selective polymer 
degradation represents a promising methodology for creating a tissue engineering scaffolds with well-
matched rates of tissue in-growth and cell-mediated scaffold degradation. Here, novel poly(thioketal) 
polymers featuring tunable chain compositions and ROS-mediated degradation rates have been 
developed towards this end. These PTK polymers were successfully incorporated into 3D porous tissue 
engineering scaffolds, generating materials with more robust mechanical properties than similar 
constructs fabricated from standard polyesters. These PTK-UR scaffolds were selectively degraded by 
ROS but were stable under aqueous conditions, indicating that their biodegradation would be 
exclusively cell-mediated as opposed to PEURs that hydrolytically degrade independent of cellular 
activity. Moreover, the in vitro oxidative degradation rates of the PTK-URs followed first-order 
degradation kinetics and displayed dose-dependent degradation with respect to ROS levels. PTK 
scaffolds exhibited cytocompatibility in vitro and were shown to be degraded by activated ROS-
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secreting macrophages. The PTK-UR scaffolds also supported cell infiltration and granulation tissue 
formation in vivo, and their superior mechanical properties lead to significantly greater stenting of 
subcutaneous implants compared to more standard PEUR scaffolds. Furthermore, the PTK-URs 
experienced controlled first-order in vivo biodegradation in contrast to the PEUR scaffolds which 
experienced dramatic increases in degradation at later time points. These collective data indicate that 
PTK-URs represent a useful new class of biomaterials that provide a robust, cell-degradable substrate 
for guiding new tissue formation.  
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CHAPTER III 
 
ONGOING AND FUTURE WORK 
 
Confirming In Vivo ROS-Dependent Scaffold Degradation 
As demonstrated in Chapter II, PTK-UR scaffolds display first order degradation kinetics both in 
vitro and in vivo. It was also clearly demonstrated that increased levels of ROS increased the 
degradation rate in vitro, though this behavior has not been confirmed in an in vivo setting. To further 
confirm the ROS-dependent nature of PTK-UR degradation, scaffolds will be implanted into 
streptozotocin (STZ)-induced diabetic rats for a 7 week time course. Oxidative stress and heightened 
ROS levels are hallmark pathogenic outcomes of diabetes70, 71, thus making an STZ-induced rat model 
ideal for studying the effects of ROS-mediated PTK-UR degradation. It is predicted that PTK-UR 
constructs will more quickly in a diabetic model than in the previously shown non-diabetic rats due to 
the higher in vivo ROS concentrations. Though higher oxidative stress has been clearly demonstrated 
in diabetic rodent models in previous work, ROS levels in the tissues of the sacrificed rats will also be 
quantitatively measured with ROS-responsive fluorescent72 or luminescent probes42 to directly tie 
heightened ROS with accelerated PTK-UR scaffold degradation. Tissue sections can also be 
processed for immunohistochemical staining with antibodies targeting macrophages, as these cells are 
known to be prime mediators of ROS production49. These studies will help confirm the ROS-dependent 
PTK-UR degradation mechanism and will further elucidate the potential in vivo performance of these 
novel materials. 
 
Critically Sized Bone Defect Model 
 Though PTK-UR scaffolds have demonstrated in vivo biocompatibility and the capacity to 
effectively regenerate soft tissue, they have not been applied for the regeneration of bone defects (the 
intended clinical application). To this end, PTK-UR scaffolds will be doped with decellularized allograft 
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bone particles as described in previous work25, 50 to increase the mechanical stiffness of the constructs 
to more appropriately match the scaffold mechanical properties with that of native bone. Furthermore, 
these scaffold composites will be loaded with recombinant human bone morphogenetic protein-2 
(rhBMP-2) as this growth factor is an essential component in promoting new bone growth25. In vitro 
testing of scaffold composites’ mechanical properties, degradation kinetics, biocompatibility, and 
rhBMP-2 release will all be performed prior to in vivo testing. Upon validation of proper scaffold 
composite in vitro performance, these materials with and without loaded rhBMP-2 will be placed in 
critically sized calvarial defects in rabbits to evaluate their ability to regenerate bone tissue over 12 
weeks.  
 
Adaptation to Other Applications 
 These novel materials have demonstrated the ability to achieve specific, ROS-mediated 
degradation both in vitro and in vivo. Most biodegradable materials used in regenerative medicine 
applications achieve degradation by incorporating hydrolytically-degradable ester bonds or protease-
degradable peptides into the polymer structure. As previously discussed in Chapter I, ester bond 
hydrolysis is non-specific and can lead to mismatches between scaffold degradation rates and tissue 
ingrowth while synthetic peptides are difficult to create on the scale needed for most tissue engineering 
applications. Thus, PTK polymers could be incorporated into many different regenerative medicine 
scaffolds for an alternative strategy to confer biodegradability to a material. In particular, thiol-
terminated PTK polymers could be incorporated into covalently cross-linked poly(ethylene glycol) 
(PEG) hydrogels by reacting the PTK thiol groups with maleimide units attached to a multi-arm PEG 
macromer73. This approach would generate a new class of cell-degradable hydrogels amenable to cell 
delivery and regeneration of soft tissues. 
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APPENDIX 
Appendix A: Supplementary Figures 
 
Figure S1. GPC chromatograms of PTK diols. 
 
 
Figure S2. SEM images of PTK-UR scaffolds. Day 0 samples (top row) show representative untreated 
scaffolds. The day 10 degradation samples (middle row) were incubated in 20% H2O2 in 0.1M CoCl2 for 
10 d at 37°C to demonstrate oxidative degradation of the PTK-URs (note visible changes in structure of 
“macro-pores” and appearance of “micro-pores” in the struts of the scaffold). Week 25 PBS samples 
(bottom row) were incubated in PBS for 25 weeks at 37°C to demonstrate the resistance of the PTKs to 
hydrolytic breakdown. White scale bar represents 600 μm, and the inset images display higher 
magnification views (2.6x magnification of large image). 
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Table S1. Thermomechanical properties of 
PTK-UR and PEUR scaffolds and neat 
polymers. 
 Polymer  Scaffold 
 
DSC Tg 
(°C) 
 DSC Tg 
(°C) 
DMA Tg 
(°C) 
100% 
MEE-PTK -66.1  -25.2 20.7 
75% 
MEE-PTK -67.7  -36.0 14.9 
50% 
MEE-PTK -78.5  -11.1 13.9 
25% 
MEE-PTK -72.9  -27.9 20.3 
0% 
MEE-PTK -76.8  -19.3 23.1 
900 Triol 
Polyester -47.7  -1.7 34.4 
1500 Triol 
Polyester -56.9  -26.4 24.7 
1000 Diol 
Polyester -43.1  -30.1 18.2 
 
 
Figure S3. In vitro oxidative degradation of the full set of PTK-UR scaffolds. Scaffolds were 
incubated in accelerated oxidative conditions (20% H2O2 in 0.1M CoCl2). For simplicity, only 100%, 50%, 
and 0% MEE-PTK-UR samples were displayed with statistical comparisons (*p < 0.05). 
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Figure S4.  H2O2 dose-dependent degradation of 900t-PEUR scaffolds. 
 
Figure S5. Subcutaneous wound lengths of implanted 100% MEE-PTK-UR and 900t-PEUR 
scaffolds. Implanted for 7 weeks, *p < 0.05. 
 
Figure S6. Subcutaneous wound areas of implanted 100% MEE-PTK-UR and 900t-PEUR 
scaffolds. Implanted for 7 weeks, *p < 0.05. 
